Persbericht

24/04/2024 TotalEnergies - Republic of Congo: TotalEnergies increases its interest in giant field Moho and divests two mature assets(24.04.2024)
24/04/2024 Atenor - Openbaarmaking over transparantiekennisgeving(24.04.2024)
24/04/2024 Deceuninck - Algemene vergadering en dividend (24.04.2024)
24/04/2024 UCB - Transparantieverklaring FMR LLC (24.04.2024)
23/04/2024 Ageas - en BNP Paribas: Transparantiekennisgeving (23.04.2024)
23/04/2024 Ageas - en Fosun: Transparantiekennisgeving (23.04.2024)
23/04/2024 ArcelorMittal - publishes its 2023 Integrated Annual Review (23.04.2024)
23/04/2024 Elia - Regeringsdelegatie benadrukt Belgische pioniersrol en expertise in offshore wind tijdens bezoek aan imposante caisson werf van het Prinses Elisabeth Eiland (23.04.2024)
23/04/2024 Telenet - Unieke samenwerking tussen Telenet Business en ICT-dienstverlener Sopra Steria maakt Belgische bedrijven digitaal futureproof (23.04.2024)
23/04/2024 Recticel - and Sika win Perifem Award for energy-saving Light Roof system (23.04.2024)
23/04/2024 Proximus - versterkt zijn mobiele aanbod en biedt zijn klanten nog meer data (23.04.2024)
23/04/2024 WERELDHAVE BELGIUM - HANDHAAFT HAAR PRESTATIENIVEAUS IN LIJN MET DE VERWACHTINGEN (23.04.2024)
23/04/2024 TheraVet - reports Full-Year 2023 Financial Results and provides the preparatory documents for the General Meeting of June 6th, 2024 (23.04.2024)
23/04/2024 Barco -Trading update 1Q24 (23.04.2024)
23/04/2024 Randstad -quarterly results. (23.04.2024)
22/04/2024 Arcelor-Mittal -U.S. Department of Energy announces financial support for ArcelorMittal’s anticipated World-Class Electrical Steel facility in Alabama (22.04.2024)
22/04/2024 TotalEnergies - signs an agreement in view of acquiring the remaining 50% of SapuraOMV, a significant Upstream Gas Operator in Malaysia (22.04.2024)
22/04/2024 TotalEnergies - launches the Marsa LNG project and deploys it multi-energy strategy in the Sultanate of Oman (22.04.2024)
22/04/2024 UCB - receives European Commission approval for BIMZELX▼(bimekizumab) as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa (22.04.2024)
22/04/2024 Mithra secures court protection measures to advance monetization process (22.04.2024)